Abstract

BackgroundTargeted mutagenesis of the herpesvirus genomes has been facilitated by the use of bacterial artificial chromosome (BAC) technology. Such modified genomes have potential uses in understanding viral pathogenesis, gene identification and characterization, and the development of new viral vectors and vaccines. We have previously described the construction of a herpes simplex virus 2 (HSV-2) BAC and the use of an allele replacement strategy to construct HSV-2 recombinants. While the BAC mutagenesis procedure is a powerful method to generate HSV-2 recombinants, particularly in the absence of selective marker in eukaryotic culture, the mutagenesis procedure is still difficult and cumbersome.ResultsHere we describe the incorporation of a phage lambda recombination system into an allele replacement vector. This strategy enables any DNA fragment containing the phage attL recombination sites to be efficiently inserted into the attR sites of the allele replacement vector using phage lambda clonase. We also describe how the incorporation of EGFP into the allele replacement vector can facilitate the selection of the desired cross-over recombinant BACs when the allele replacement reaction is a viral gene deletion. Finally, we incorporate the lambda phage recombination sites directly into an HSV-2 BAC vector for direct recombination of gene cassettes using the phage lambda clonase-driven recombination reaction.ConclusionTogether, these improvements to the techniques of HSV BAC mutagenesis will facilitate the construction of recombinant herpes simplex viruses and viral vectors.

Highlights

  • Targeted mutagenesis of the herpesvirus genomes has been facilitated by the use of bacterial artificial chromosome (BAC) technology

  • Since the initial report that described the BAC cloning of a murine cytomegalovirus genome [2], several additional herpesvirus genomes have been cloned as BACs [3,4,5,6,7,8,9,10,11,12,13,14], including herpes simplex virus 1 (HSV-1) and herpes simplex 2 (HSV-2) [15,16,17,18]

  • Any DNA fragment containing attL recombination sites can be efficiently inserted into the attR sites in the pKO5.2-C.1 vector using phage lambda clonase, and the resultant recombinant plasmids are ready for the allele replacement reaction

Read more

Summary

Introduction

Targeted mutagenesis of the herpesvirus genomes has been facilitated by the use of bacterial artificial chromosome (BAC) technology. Such modified genomes have potential uses in understanding viral pathogenesis, gene identification and characterization, and the development of new viral vectors and vaccines. BMC Biotechnology 2007, 7:22 http://www.biomedcentral.com/1472-6750/7/22 genome without the need for typical selective mechanisms required for mutagenesis and selection in eukaryotic cells This allows for the generation of viral mutants that would be difficult to obtain otherwise, either because of the lack of a phenotypic effect due to mutation or because the mutation confers a disadvantage for selection and replication in eukaryotic cells. Modified viral genomes have potential uses in other areas such as the construction and development of novel viral vectors and vaccines

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call